The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome
JAMA Dermatol
.
2024 Jan 1;160(1):117.
doi: 10.1001/jamadermatol.2023.4767.
Authors
Hamza Malick
1
,
Kyle Lauck
2
,
Dario Kivelevitch
2
Affiliations
1
Texas A&M School of Medicine, Dallas.
2
Department of Dermatology, Baylor University Medical Center, Dallas, Texas.
PMID:
38055233
DOI:
10.1001/jamadermatol.2023.4767
No abstract available
MeSH terms
Cyclosporine* / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Stevens-Johnson Syndrome* / drug therapy
Stevens-Johnson Syndrome* / etiology
Substances
Cyclosporine
Immunosuppressive Agents